ArborGen Holdings

Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Equities
Equities
View All Equities
Equities by Sector

Consumer

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Oil & Gas

Real Estate

TMT

Pharnext

MCap

EUR1m

Last close

EUR0.10

▲ 0.06 (150.00%)

Actinogen Medical

MCap

AUD48m

Last close

AUD0.03

▲ 0.01 (50.00%)

DFR Gold

MCap

CAD13m

Last close

CAD0.10

▲ 0.03 (42.86%)
Sectors
Sectors
Investment Strategy
Investment Strategy
View All

Latest
Thematics
Thematics
View All Thematics

Latest

Events
About Edison
About Edison
About Edison

Careers

“Edison’s accessible and high-quality research gives us the opportunity to communicate an independent perspective of Tyman to a wide variety of potential stakeholders.”

James Brotherton Financial Director — Tyman
Equity Research
Investor Relations
Contact us

ArborGen Holdings (NZX: ARB)

Currency in NZD

Last close As at 27/09/2023

NZD0.18

▲ −0.01 (−5.26%)

Market capitalisation

NZD96m

Overview
Price performance
Financials
Research
Thematics

ArborGen Holdings is a New Zealand-listed investment company and is the world’s largest integrated developer, commercial manufacturer and supplier of advanced forestry seedlings with operations in the United States and Brazil.

Prior to the COVID-19 outbreak, the economic growth outlook in each of its core countries, the United States and Brazil, was either good or improving, according to OECD data. At this point the primary end-markets served by ArborGen’s plantation forestry customer base were in a positive cyclical phase.

Latest Insights

Industrials |
Outlook

24.07.23

ArborGen Holdings — Green shoots appear in the spring

Industrials |
Update

07.12.22

ArborGen Holdings — Seedling supplier’s long-term future looks green

Industrials |
Update

30.06.22

ArborGen Holdings — Shifting focus to US South and Brazil

Industrials |
Update

23.06.21

ArborGen Holdings — Favourable balance of risk

Visit Website

Sector

Industrials

Equity Analyst

Andy Murphy

Director, Financials & Industrials

Key Management

Alex Brown

CFO
Dave Knott, Jr

Chairman
Justin Birch

President and CEO
Sharon Ludher-Chandra

Business Development Executive

Balance Sheet

Forecast net debt (US$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
%	1M	3M	12M
Actual	(10.0)	(10.0)	(23.4)
Relative	(6.7)	(6.9)	(20.2)
52 week high/low	0.2/0.2

Financials

We believe ArborGen Holdings is in prime position, not only to address increasing demands from clients for its seedlings, but also for its ongoing investment in genetic improvement to continue to drive the switch to sales of higher-value, higher-margin seedlings to all its key markets. While this process plays out, underlying EBIT is set to increase five-fold in the next two years as gross margins return to and then exceed historical levels. We determine a value of NZ$0.49/share, implying attractive upside.